Shares of Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.42 and traded as low as $0.32. Northwest Biotherapeutics shares last traded at $0.33, with a volume of 931,730 shares.
Northwest Biotherapeutics Price Performance
The stock has a market cap of $400.02 million, a P/E ratio of -4.64 and a beta of -0.58. The stock’s 50 day simple moving average is $0.33 and its two-hundred day simple moving average is $0.42.
Northwest Biotherapeutics (OTCMKTS:NWBO – Get Free Report) last released its earnings results on Friday, August 9th. The biotechnology company reported ($0.02) earnings per share (EPS) for the quarter. The company had revenue of $0.51 million during the quarter.
Northwest Biotherapeutics Company Profile
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer.
See Also
- Five stocks we like better than Northwest Biotherapeutics
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- Where to Find Earnings Call Transcripts
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- What is a Stock Market Index and How Do You Use Them?
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
